Physical medicine and rehabilitation

Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy

Retrieved on: 
星期一, 五月 20, 2024
Doctor of Philosophy, SCI, Sleep, Sensation, Food, University, Safety, MD, Swiss, De novo, Computer engineering, Spinal cord, Movement, EPFL, Euronext, ARC, Electricity, Physical medicine and rehabilitation, Arm, BCI, Neurotechnology, Webcast, Quality of life, Lausanne University Hospital, Neurosurgery, Pharmaceutical industry

EINDHOVEN, the Netherlands, May 20, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces the publication of global Up-LIFT pivotal trial results in Nature Medicine. The study achieved all primary safety and effectiveness endpoints, and ARC-EX Therapy demonstrated significant improvements in upper limb strength, function, and sensation among people with chronic tetraplegia due to cervical SCI.

Key Points: 
  • The study achieved all primary safety and effectiveness endpoints, and ARC-EX Therapy demonstrated significant improvements in upper limb strength, function, and sensation among people with chronic tetraplegia due to cervical SCI.
  • Notably, the number of responders increased to 90% when the definition included participants with improvements in at least one strength or functional outcome*.
  • 87% of participants reported that ARC-EX Therapy delivered improvements in overall quality of life*.
  • “Improvement in arm and hand function is among the highest priorities for people with tetraplegia3 who have endured far too long without effective therapies for functional recovery,” said Dave Marver, CEO, ONWARD Medical.

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Retrieved on: 
星期二, 五月 21, 2024
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Physical medicine and rehabilitation, Organization, SCI, Clinical trial, University, Therapy, New Jersey Medical School, Person, Neurosurgery, BCI, Rehabilitation, Pharmaceutical industry

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS").

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS").
  • “Through our initiatives to raise awareness and increase collaboration in the field of spinal cord injury, we have encountered an enthusiastic response to this conference from a diverse and innovative group of companies and other stakeholders.
  • “We are excited to add a BCI-focused clinical session this year with the inclusion of Neuralink and several additional corporate presenters.
  • , Chief Medical Officer, Kessler Foundation, Professor of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School

AOSMI Announces Service Expansion in Belmar, NJ, With Support from Health Plus Management

Retrieved on: 
星期二, 五月 14, 2024
Physical medicine and rehabilitation, Patient, Health, Pain management, Interventional pain management, Orthopedic surgery, MBA, MD, Elective surgery, CPE, ACGME, Regenerative medicine, Rehabilitation, Partner (business rank)

BELMAR, N.J., May 14, 2024 /PRNewswire/ -- Advanced Orthopedics and Sports Medicine Institute (AOSMI) is excited to announce the expansion of its comprehensive orthopedics services in Belmar, New Jersey.

Key Points: 
  • BELMAR, N.J., May 14, 2024 /PRNewswire/ -- Advanced Orthopedics and Sports Medicine Institute (AOSMI) is excited to announce the expansion of its comprehensive orthopedics services in Belmar, New Jersey.
  • This initiative underscores AOSMI's commitment to providing the community with specialized orthopedic and sports medicine care.
  • Central to this expansion at AOSMI's Belmar location, 712 10th Ave, are Dr. Stacey Gallacher and Dr. Ali Valimahomed, whose expertise significantly enhances AOSMI's offerings.
  • With a focus on delivering exceptional clinical results, supported by cutting-edge treatments and compassionate care, AOSMI is set to continue its mission of providing the highest level of comprehensive musculoskeletal services.

Gaxos Health Expands Medical Advisory Board

Retrieved on: 
星期四, 四月 25, 2024
Physical medicine and rehabilitation, Johns Hopkins University, Health care, Sport, Abstract, Testosterone, Private practice, MD, Columbia University, PRP, Intelligence, New York (magazine), Prostate cancer, Erectile dysfunction, Cornell University, Drug, Spine, Patient, Bachelor of Arts, Rehabilitation, Public key certificate, Seton Hall University, Medical Center, Hormone replacement therapy, Injury, Partner, Medical device

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.

Key Points: 
  • Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.
  • “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI.
  • “An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders.”
    Dr. Eric Margolis, M.D.
  • “We welcome Dr. Margolis and Dr. Pavell to the advisory board as their experience and insight will allow us to create a more fine-tuned solution,” Vadim Mats added.

California State Superintendent of Instruction Tony Thurmond Tapped as Keynote Speaker at Inland Empire Education and Workforce Summit

Retrieved on: 
星期四, 四月 25, 2024
Education, Kaiser Permanente, Achievement Medal, Expansion, Investment, State, School, Health, Partnership, Conference, Convention center, STEM, Think Together, Physical medicine and rehabilitation, Commerce, Driver's education, Workforce, Century, Eisenhower High School, Student, COVID-19, Management

ONTARIO, Calif., April 25, 2024 /PRNewswire/ -- Think Together, California's leading nonprofit provider of afterschool, expanded learning, and school improvement programs, in partnership with the Inland Empire Regional Chamber of Commerce, hosted its fourth annual Inland Empire Education and Workforce Summit at the Ontario Airport Hotel and Conference Center on April 24.

Key Points: 
  • In partnership with Think Together and the Inland Empire Regional Chamber of Commerce, the fourth annual summit tackled post-pandemic issues still impacting education and workforce readiness.
  • The summit opened with Dr. Alex McDonald from Kaiser Permanente, to share how healthcare intersects with education and workforce development.
  • Participants included:
    To round out the summit, California Superintendent of Public Instruction Tony Thurmond gave this year's keynote address, emphasizing the importance of equitable access to quality education and the need for continued collaboration between educators, policymakers, and community stakeholders.
  • "Afterschool programs that expose students to career-ready learning experiences create a critical bridge between school-day learning and future success," said State Superintendent of Public Instruction, Tony Thurmond.

Applications for the American Board of Medical Specialties 2024-2025 Visiting Scholars Program are Now Available

Retrieved on: 
星期三, 四月 10, 2024
Public, Physical medicine and rehabilitation, Cardiothoracic surgery, Health, Certification, Travel, Veterans' affairs, Medical specialty, Research, Statistics, Mentorship, Rehabilitation, Partnership, Conference, Curriculum, Obstetrics, Gynaecology, Orthopedic surgery, Visa, ABMS, Urology, Immunology, Physician, CDT, Dissemination, Emergency medicine, Nursing

CHICAGO, April 10, 2024 /PRNewswire/ --The American Board of Medical Specialties (ABMS) is now accepting applications for the 10th year of its Visiting Scholars Program. This one-year, part-time program positions early-career physicians and research professionals as active contributors and future leaders in health care. Applications must be received by 11:59 pm CDT on June 17, 2024. Since the program's 2014 inception, 64 individuals have participated.

Key Points: 
  • Informational Webinar Scheduled for April 23, 2024
    CHICAGO, April 10, 2024 /PRNewswire/ --The American Board of Medical Specialties (ABMS) is now accepting applications for the 10th year of its Visiting Scholars Program.
  • This one-year, part-time program positions early-career physicians and research professionals as active contributors and future leaders in health care.
  • The ABMS Visiting Scholars Program allows participants to:
    Conduct research of value to their home institutions and the larger certification community.
  • A free, hour-long informational webinar to learn more about the ABMS Visiting Scholars Program will be held on April 23, 2024 at 5:00 pm CDT.

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia

Retrieved on: 
星期三, 三月 13, 2024
TENS, Fibromyalgia, Label, Patient, Contraindication, Sleep, Sale, Rehabilitation, Physical medicine and rehabilitation, Consultant, Pain

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022.

Key Points: 
  • WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022.
  • “We have been pleased by the positive response to Quell Fibromyalgia from providers taking care of patients with fibromyalgia during our strategic launch phase,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix.
  • In my practice, we have even had some patients report they were able to reduce pain with Quell Fibromyalgia that medications have never helped before."
  • The sale, distribution, and use of Quell Fibromyalgia is restricted to prescription use in accordance with 21 CFR 801.109.

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹

Retrieved on: 
星期二, 二月 20, 2024
PALO, Prevalence, Neck pain, Lidocaine, Physical medicine and rehabilitation, Neurology, Anesthesiology, American Medical Association, JAMA, Outline of health sciences, Disability, Chronic pain, Behavioural sciences, COVID, Patient, Journal, Neck, Psychiatry, Clutch (eggs), Rehabilitation, Pharmaceutical industry

PALO ALTO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced publication in Anesthesiology Journal of results from an investigator-initiated research study using ZTlido® for the treatment of chronic neck pain.

Key Points: 
  • PALO ALTO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced publication in Anesthesiology Journal of results from an investigator-initiated research study using ZTlido® for the treatment of chronic neck pain.
  • The primary outcome measure was mean reduction in average neck pain coupled with the Patient Global Impression of Change.
  • Neck pain, or cervicalgia, is one of the most common pain presentations in U.S. and the 4th leading cause of disability.
  • According to a 2020 JAMA publication (Journal of the American Medical Association), the U.S. low back and neck pain market is estimated at $134.5B.4

DocNow Raises Seed Round to Further Expand Next Generation Electronic Health Record (EHR) System for Post-Acute Care Providers

Retrieved on: 
星期四, 三月 7, 2024
Mental health, History, EHR, Cardiology, Physical medicine and rehabilitation, Electronic health record, Internal medicine, Waterline, Patient, Automation, Psychiatry, Rehabilitation, Nursing

BELLEVUE, Wash., March 7, 2024 /PRNewswire/ -- DocNow , a provider of Electronic Health Record (EHR) and wound care management solutions for Post-Acute Care providers, today announced it has closed a Series Seed round led by Waterline Ventures .

Key Points: 
  • BELLEVUE, Wash., March 7, 2024 /PRNewswire/ -- DocNow , a provider of Electronic Health Record (EHR) and wound care management solutions for Post-Acute Care providers, today announced it has closed a Series Seed round led by Waterline Ventures .
  • DocNow was designed by a physician who was frustrated with the inefficiencies of legacy Post-Acute Care systems.
  • DocNow services several specialties including Physical Medicine and Rehabilitation, Cardiology / Pulmonology, Behavioral Health (Psychiatry + Psychology), and Internal Medicine.
  • DocNow offers assistive note generation, advanced templating, and multiple other tools to help providers efficiently complete their work.

Mediplex Property Group Opens New State-of-the-Art Location for Rothman Orthopaedics in Newtown, PA

Retrieved on: 
星期二, 二月 13, 2024
Doctor of Philosophy, MD, Hospital, Growth, Occupational therapy, Physical medicine and rehabilitation, MBA, Physical therapy, Patient, Hand Therapy, Neurosurgery, Foot, OceanFirst Bank, Sports medicine, Thomas Jefferson

NEWTOWN, Pa., Feb. 13, 2024 /PRNewswire/ -- Mediplex Property Group proudly announces the opening of Mediplex Newtown, the latest addition to its rapidly expanding portfolio of healthcare focused real estate.

Key Points: 
  • NEWTOWN, Pa., Feb. 13, 2024 /PRNewswire/ -- Mediplex Property Group proudly announces the opening of Mediplex Newtown, the latest addition to its rapidly expanding portfolio of healthcare focused real estate.
  • The property is leased in its entirety to Rothman Orthopaedic Institute, an internationally recognized leader in orthopedic care.
  • The prime corner location at 101 Pheasant Run replaces Rothman Orthopaedics' previous facility in Newtown.
  • Additionally, a larger location allows Rothman Orthopaedics to offer walk-in services, giving patients immediate access without the need for an appointment.